Feinsod Matthew 4

4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Apr 15, 2019

Insider Transaction Report

Form 4
Period: 2019-04-11
Feinsod Matthew
Interim Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-04-11$4.61/sh606$2,79452,014 total
  • Award

    Common Stock

    2019-04-11+2,00052,620 total
Footnotes (1)
  • [F1]The common stock vested immediately upon grant.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT